Please turn JavaScript on
Tech Funding News icon

Tech Funding News

Want to know the latest news and articles posted on Tech Funding News?

Then subscribe to their feed now! You can receive their updates by email, via mobile or on your personal news page on this website.

See what they recently published below.

Website title: Tech Funding News | Global technology startup funding news

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  9 / day

Message History

Cerebras has lifted its IPO price range to $150–$160 per share, up from $115–$125, targeting up to $4.8B in proceeds on Nasdaq. The AI chipmaker reported $510M in 2025 revenue, up 76% year on year, and holds a $20B-plus compute deal with OpenAI. Cerebras could be valued at up to $48.8B on a fully diluted basis.


Read full story
Circle has raised $222M through a token presale for Arc.  a16z crypto led the round with $75M, with BlackRock, Apollo, and Standard Chartered Ventures Circle is the first publicly listed company to conduct a token presale before a blockchain launch

Circle has raised


Read full story
Wise has transferred its primary stock market listing from London to New York, making its NASDAQ debut after first listing in the UK in 2021 The fintech handled $243B in cross-border volume in the year to March 31, up 31% year-on-year The move raises fresh questions about London’s ability to retain major technology companies, as the US market offers deeper liquidity ...

Read full story
UK’s National Wealth Fund has invested £25 million in Bristol-based Rowden. The funding will support two new sites in the Southwest and West Midlands, while creating 100 jobs in the next year and 500 by 2032. Rowden is scaling exports of its UK-developed sensing, computing, and networking systems used by the British Army, emergency services, and overseas customers. ...

Read full story
Isomorphic Labs has secured $2.1 billion in Series B funding led by Thrive Capital, with backing from Alphabet, GV, MGX, Temasek, CapitalG, and the UK Sovereign AI Fund. The London-based company plans to use the fresh capital to expand its AI drug design engine, accelerate therapeutic programs into clinical stages, and hire top scientific and engineering talent globally. ...

Read full story